RT Journal
A1 Wilkins J, Wehrle PF
T1 FUrther evaluation of the optimum age for rubella vaccine administration
JF American Journal of Diseases of Children
JO American Journal of Diseases of Children
YR 1979
FD December 1
VO 133
IS 12
SP 1237
OP 1239
DO 10.1001/archpedi.1979.02130120029004
UL http://dx.doi.org/10.1001/archpedi.1979.02130120029004
AB • The hemagglutination-inhibition (HI) antibody responses of 452 children to HPV-77,DE5 rubella vaccine were studied. Results indicated that seroconversion rates and geometric mean titers in infants inoculated at 12 through 14 months of age are comparable with those achieved in older children. "Vaccine failures" seem to occur randomly in vaccinees after 1 year of age; the infectivity of individual vaccines is questioned. The persistence of HI antibody was evaluated through serial sampling up to three years postinoculation.(Am J Dis Child 133:1237-1239, 1979)